
SunGran Injection is a new and high-tech product on gene engineering, which is researched by Academy of Military Medical Sciences and is manufactured by Shanghai Sunway Biotech Co., Ltd. It is a recombinant human granulocyte-colony stimulating factor which is used recombinant DNA technology. SunGran has the same biological activity with natural human granulocyte -colony stimulating factor. The product is granted a significant scientific-research achievement of national high-tech research “863” plan on biological high-tech.
SunGran was approved as national significant new product and got a certificate by five national ministries and commissions in 2002.
SunGran was begun export on December, 2004. It is selled in India and Pakistan at present.
rhG-CSF is a new high-tech product on biological engineering. It was approved by FDA (the United State) in 1991. rhG-CSF can increase leukocyte rapidly. Its curative effect is significant and side effect is slight. rhG-CSF is the first choice on treating the lack of leukocyte in clinical at present.
Some hematopoietic cytokines, such as G-CSF, which have single effect in development process of myeloid stem cells and act on late phase of hematopoietic stem cell differentiation, have a significant curative effect and slight side effects in clinical. While others, which have general effects or early phase, have a bigger side effect in clinical.
The market share of G-CSF is much larger than other hematopoietic cytokines in current domestic and foreign markets. Besides, It has a good market in gene engineering products.